These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34921093)

  • 1. Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus.
    Bolla E; Tentolouris N; Sfikakis PP; Tektonidou MG
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34921093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques.
    Bolla E; Tentolouris N; Sfikakis PP; Tektonidou MG
    Front Immunol; 2022; 13():1077166. PubMed ID: 36700208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.
    Panopoulos S; Thomas K; Georgiopoulos G; Boumpas D; Katsiari C; Bertsias G; Drosos AA; Boki K; Dimitroulas T; Garyfallos A; Papagoras C; Katsimbri P; Tziortziotis A; Adamichou C; Kaltsonoudis E; Argyriou E; Vosvotekas G; Sfikakis PP; Vassilopoulos D; Tektonidou MG
    Rheumatology (Oxford); 2021 Jan; 60(1):170-178. PubMed ID: 32596727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries.
    Bolla E; Semb AG; Kerola AM; Ikdahl E; Petri M; Pons-Estel GJ; Karpouzas GA; Sfikakis PP; Quintana R; Misra DP; Borba EF; Garcia-de la Torre I; Popkova TV; Artim-Esen B; Troldborg A; Fragoso-Loyo H; Ajeganova S; Yazici A; Aroca-Martinez G; Direskeneli H; Ugarte-Gil MF; Mosca M; Goyal M; Svenungsson E; Macieira C; Hoi A; Lerang K; Costedoat-Chalumeau N; Tincani A; Mirrakhimov E; Acosta Colman I; Danza A; Massardo L; Blagojevic J; Yılmaz N; Tegzová D; Yavuz S; Korkmaz C; Hachulla E; Moreno Alvarez MJ; Muñoz-Louis R; Pantazis N; Tektonidou MG;
    Lancet Rheumatol; 2024 Jul; 6(7):e447-e459. PubMed ID: 38878780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-year follow-up atherosclerotic plaque progression in patients with antiphospholipid syndrome versus diabetes mellitus and healthy controls.
    Evangelatos G; Tentolouris N; Sfikakis PP; Tektonidou MG
    Rheumatology (Oxford); 2024 Feb; ():. PubMed ID: 38321577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerosis progression in antiphospholipid syndrome is comparable to diabetes mellitus: a 3 year prospective study.
    Evangelatos G; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Tektonidou MG
    Rheumatology (Oxford); 2022 Aug; 61(8):3408-3413. PubMed ID: 34850863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit.
    Semb AG; Rollefstad S; Ikdahl E; Wibetoe G; Sexton J; Crowson C; van Riel P; Kitas G; Graham I; Rantapää-Dahlqvist S; Karpouzas GA; Myasoedova E; Gonzalez-Gay MA; Sfikakis PP; Tektonidou MG; Lazarini A; Vassilopoulos D; Kuriya B; Hitchon C; Stoenoiu MS; Durez P; Pascual-Ramos V; Galarza-Delgado DA; Faggiano P; Misra DP; Borg AA; Mu R; Mirrakhimov EM; Gheta D; Douglas K; Agarwal V; Myasoedova S; Krougly L; Valentinovna Popkova T; Tuchyňová A; Tomcik M; Vrablik M; Lastuvka J; Horak P; Medkova HK; Kerola AM;
    RMD Open; 2021 Jul; 7(2):. PubMed ID: 34244381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study.
    Vlachoyiannopoulos PG; Kanellopoulos PG; Ioannidis JP; Tektonidou MG; Mastorakou I; Moutsopoulos HM
    Rheumatology (Oxford); 2003 May; 42(5):645-51. PubMed ID: 12709540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.
    Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Tektonidou MG
    Semin Arthritis Rheum; 2018 Jun; 47(6):883-889. PubMed ID: 29150207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial stiffness tested by pulse wave velocity and augmentation index for cardiovascular risk stratification in antiphospholipid syndrome.
    Evangelatos G; Konstantonis G; Tentolouris N; Sfikakis PP; Tektonidou MG
    Rheumatology (Oxford); 2024 Apr; 63(4):1030-1038. PubMed ID: 37294733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Traditional risk factors for cardiovascular disease in primary antiphospholipid syndrome (APS) when compared with secondary APS: a study with 96 patients].
    Ribeiro AR; Carvalho JF
    Acta Reumatol Port; 2010; 35(1):36-41. PubMed ID: 20505627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus.
    Papazoglou N; Kravvariti E; Konstantonis G; Sfikakis PP; Tektonidou MG
    Rheumatology (Oxford); 2024 Jan; 63(1):50-57. PubMed ID: 37086440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.
    Tektonidou MG; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Protogerou A
    Autoimmun Rev; 2017 Mar; 16(3):308-312. PubMed ID: 28147263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis.
    Tektonidou MG
    J Autoimmun; 2022 Apr; 128():102813. PubMed ID: 35247655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis.
    Chung CP; Giles JT; Petri M; Szklo M; Post W; Blumenthal RS; Gelber AC; Ouyang P; Jenny NS; Bathon JM
    Semin Arthritis Rheum; 2012 Feb; 41(4):535-44. PubMed ID: 22340996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer.
    Sun L; Parikh RB; Hubbard RA; Cashy J; Takvorian SU; Vaughn DJ; Robinson KW; Narayan V; Ky B
    JAMA Netw Open; 2021 Feb; 4(2):e210070. PubMed ID: 33625512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years.
    Ajeganova S; Hafström I; Frostegård J
    Lupus Sci Med; 2021 Feb; 8(1):. PubMed ID: 33547230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiphospholipid syndrome in patients with systemic connective tissue diseases].
    Unikiene D; Misiūniene N
    Medicina (Kaunas); 2003; 39(5):454-9. PubMed ID: 12794367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Luque-Tévar M; Torres-Granados C; Aguirre-Zamorano MA; Collantes-Estevez E; Pérez-Sánchez C
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.